The US Senate's approval this week of legislation to strengthen the Food and Drug Administration could spark reform in an agency often accused by consumer groups of lacking effectiveness. The text, adopted by a vote of 93-1, aims to boost certain FDA regulatory powers and help restore the public's shaken confidence following a series of scandals in recent years.


Comments